Keck F S, Wolf C F, Foldenauer A, Zeller G, Kerner W, Pfeiffer E F
Medizinische Klinik und Poliklinik, Universität Ulm, Fed. Rep. of Germany.
Arzneimittelforschung. 1991 Jan;41(1):6-9.
The influence of a series of sympathomimetic agents on the liver content of non protein bound thiol groups (NP-SH), mainly representing glutathione, has been assessed in the male rat. The rats were intravenously and/or subcutaneously infused over 6 h at different dosages either with dopamine, dobutamine, epinephrine, terbutaline, or phentolamine, or simultaneously with dopamine and phentolamine, or with epinephrine and phentolamine. Besides NP-SH, total sulfhydryl group content was measured in liver cytosol, while glucose and insulin concentrations were determined in the serum. Liver NP-SH content was significantly decreased by epinephrine. This decrease was abolished and even inverted to an increase, when appropriate doses of phentolamine were infused simultaneously. Dopamine caused a rise in NP-SH content at a dose rate of 7.5 micrograms/kg.min, while lower and higher dose rates of dopamine exerted not any influence on liver NP-SH. When phentolamine was concomitantly infused with 15 micrograms/kg.min of dopamine, NP-SH was significantly elevated. Phentolamine, when infused exclusively, increased NP-SH as well, while it was not influenced, however, by terbutaline or dobutamine at any dosage. Cytosolic total sulfhydryls were found to be unaltered across all experimental groups. When the NP-SH values are related to the corresponding serum insulin levels, a close and linear relationship becomes evident. The study demonstrates, that some sympathomimetic agents can exert a considerable influence on hepatic non protein bound thiol content. The data suggest, that the varying liver NP-SH content under adrenergic drugs is primarily related to changes in serum insulin concentration.(ABSTRACT TRUNCATED AT 250 WORDS)
在雄性大鼠中评估了一系列拟交感神经药对肝脏中非蛋白结合巯基(NP-SH,主要代表谷胱甘肽)含量的影响。大鼠分别以不同剂量静脉内和/或皮下注射多巴胺、多巴酚丁胺、肾上腺素、特布他林或酚妥拉明6小时,或同时注射多巴胺和酚妥拉明,或肾上腺素和酚妥拉明。除了NP-SH外,还测定了肝细胞质中的总巯基含量,同时测定了血清中的葡萄糖和胰岛素浓度。肾上腺素可使肝脏NP-SH含量显著降低。当同时注射适当剂量的酚妥拉明时,这种降低被消除,甚至转为升高。多巴胺以7.5微克/千克·分钟的剂量率可使NP-SH含量升高,而较低和较高剂量率的多巴胺对肝脏NP-SH无任何影响。当酚妥拉明与15微克/千克·分钟的多巴胺同时注射时,NP-SH显著升高。单独注射酚妥拉明时也可使NP-SH升高,然而,任何剂量的特布他林或多巴酚丁胺对其均无影响。所有实验组的细胞质总巯基均未改变。当将NP-SH值与相应的血清胰岛素水平相关联时,明显呈现出密切的线性关系。该研究表明,一些拟交感神经药可对肝脏非蛋白结合巯基含量产生相当大的影响。数据表明,肾上腺素能药物作用下肝脏NP-SH含量的变化主要与血清胰岛素浓度的变化有关。(摘要截短至250字)